UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer

Japanese journal of clinical oncology, 2022-10, Vol.52 (10), p.1089-1096

2022

Volltextzugriff (PDF)

Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

BMC gastroenterology, 2020-07, Vol.20 (1), p.217-9, Article 217

2020

Volltextzugriff (PDF)

Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.e7401-n/a

2024

Volltextzugriff (PDF)

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin

Esophagus : official journal of the Japan Esophageal Society, 2023-01, Vol.20 (1), p.109-115

2023

Volltextzugriff (PDF)

Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab

Cancer medicine (Malden, MA), 2023-04, Vol.12 (8), p.9322-9331

2023

Volltextzugriff (PDF)

A case of pembrolizumab responding to recurrent small bowel mucinous adenocarcinoma with Peutz-Jeghers syndrome

Nippon Shokakibyo Gakkai Zasshi, 2021/11/10, Vol.118(11), pp.1063-1070

2021

Volltextzugriff (PDF)

Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma

Future oncology (London, England), 2024-05, p.1-11

2024

Volltextzugriff (PDF)

Idiopathic hypereosinophilic syndrome with formation of multiple liver mass lesions

Clinical journal of gastroenterology, 2020-10, Vol.13 (5), p.834-838

2020

Volltextzugriff (PDF)

Peutz-Jeghers症候群に合併した再発小腸粘液癌に対しPembrolizumabが奏効した1例

日本消化器病学会雑誌, 2021/11/10, Vol.118(11), pp.1063-1070

2021

Volltextzugriff (PDF)

Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.322-322

2023

Volltextzugriff (PDF)

The impact of claudin-18.2 expression in patients with advanced gastric cancer treated with nivolumab

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.439-439

2023

Volltextzugriff (PDF)

The association between trophoblast cell surface antigen 2 expression and nivolumab monotherapy in patients with advanced gastric cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.438-438

2023

Volltextzugriff (PDF)

Narrative review of malignant ascites: epidemiology, pathophysiology, assessment, and treatment

Annals of palliative medicine, 2024-07, Vol.13 (4), p.842-857

2024

Volltextzugriff (PDF)

Safety and efficacy of prophylactic pegfilgrastim on day 3 of neoadjuvant DCF chemotherapy in elderly patients with resectable esophageal cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.375-375

2023

Volltextzugriff (PDF)

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.373-373

2023

Volltextzugriff (PDF)

Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.317-317

2023

Volltextzugriff (PDF)

Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.312-312

2023

Volltextzugriff (PDF)

270. SAFETY AND EFFICACY OF PREOPERATIVE FOLFOX FOR PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA WHO ARE NOT CANDIDATES FOR CISPLATIN

Diseases of the esophagus, 2022-09, Vol.35 (Supplement_2)

2022

Volltextzugriff (PDF)

Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses

Journal of gastrointestinal cancer, 2024-07

2024

Volltextzugriff (PDF)

Malignancy-related ascites in palliative care units: prognostic factor analysis

BMJ supportive & palliative care, 2023-12, Vol.13 (e3), p.e1292

2023

Volltextzugriff (PDF)

Resurfacing processes on asteroid (162173) Ryugu caused by an artificial impact of Hayabusa2's Small Carry-on Impactor

Icarus (New York, N.Y. 1962), 2021-09, Vol.366, p.114530, Article 114530

2021

Volltextzugriff (PDF)

Cerebral Salt-wasting Syndrome and Inappropriate Antidiuretic Hormone Syndrome after Subarachnoid Hemorrhaging

Internal Medicine, 2017/03/15, Vol.56(6), pp.677-680

2017

Volltextzugriff (PDF)

Postoperative outcomes of major lower extremity amputations in patients with diabetes and peripheral artery disease: analysis using the Diagnosis Procedure Combination database in Japan

The American journal of surgery, 2016-09, Vol.212 (3), p.446-450

2016

Volltextzugriff (PDF)

construction of an EST database for Bombyx mori and its application

Proceedings of the National Academy of Sciences - PNAS, 2003-11, Vol.100 (24), p.14121-14126

2003

Volltextzugriff (PDF)

Etiological role of human papillomavirus infection in the development of penile cancer

International journal of infectious diseases, 2019-01, Vol.78, p.148-154

2019

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(70)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer

Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real‐world analysis

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin

Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab

A case of pembrolizumab responding to recurrent small bowel mucinous adenocarcinoma with Peutz-Jeghers syndrome

Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma

Idiopathic hypereosinophilic syndrome with formation of multiple liver mass lesions

Peutz-Jeghers症候群に合併した再発小腸粘液癌に対しPembrolizumabが奏効した1例

Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer

The impact of claudin-18.2 expression in patients with advanced gastric cancer treated with nivolumab

The association between trophoblast cell surface antigen 2 expression and nivolumab monotherapy in patients with advanced gastric cancer

Narrative review of malignant ascites: epidemiology, pathophysiology, assessment, and treatment

Safety and efficacy of prophylactic pegfilgrastim on day 3 of neoadjuvant DCF chemotherapy in elderly patients with resectable esophageal cancer

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma

Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma

Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma

270. SAFETY AND EFFICACY OF PREOPERATIVE FOLFOX FOR PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA WHO ARE NOT CANDIDATES FOR CISPLATIN

Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses

Malignancy-related ascites in palliative care units: prognostic factor analysis

Resurfacing processes on asteroid (162173) Ryugu caused by an artificial impact of Hayabusa2's Small Carry-on Impactor

Cerebral Salt-wasting Syndrome and Inappropriate Antidiuretic Hormone Syndrome after Subarachnoid Hemorrhaging

Postoperative outcomes of major lower extremity amputations in patients with diabetes and peripheral artery disease: analysis using the Diagnosis Procedure Combination database in Japan

construction of an EST database for Bombyx mori and its application

Etiological role of human papillomavirus infection in the development of penile cancer

Suchergebnisse filtern